Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV

Journal of Acquired Immune Deficiency Syndromes : JAIDS
Richard A ElionNorth American AIDS Cohort Collaboration on Research and Design of IeDEA

Abstract

There is persistent confusion as to whether abacavir (ABC) increases the risk of myocardial infarction (MI), and whether such risk differs by type 1 (T1MI) or 2 (T2MI) MI in adults with HIV. Incident MIs in North American Cohort Collaboration on Research and Design participants were identified from 2001 to 2013. Discrete time marginal structural models addressed channeling biases and time-dependent confounding to estimate crude hazard ratio (HR) and adjusted hazard ratio (aHR) and 95% confidence intervals; analyses were performed for T1MI and T2MI separately. A sensitivity analysis evaluated whether Framingham risk score (FRS) modified the effect of ABC on MI occurrence. Eight thousand two hundred sixty-five adults who initiated antiretroviral therapy contributed 29,077 person-years and 123 MI events (65 T1MI and 58 T2MI). Median follow-up time was 2.9 (interquartile range 1.4-5.1) years. ABC initiators were more likely to have a history of injection drug use, hepatitis C virus infection, hypertension, diabetes, impaired kidney function, hyperlipidemia, low (<200 cells/mm) CD4 counts, and a history of AIDS. The risk of the combined MI outcome was greater for persons who used ABC in the previous 6 months [aHR = 1.84 (1.17-2.91)]...Continue Reading

References

Jan 1, 1999·Lancet·A Carr, D A Cooper
Aug 24, 2000·Epidemiology·J M RobinsB Brumback
Dec 14, 2002·Lancet·Scott D HolmbergUNKNOWN HIV Outpatient Study (HOPS) investigators
Oct 31, 2003·American Journal of Epidemiology·Wayne A Ray
Jan 11, 2007·International Journal of Epidemiology·Stephen J GangeRichard D Moore
Sep 21, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert C KaplanStephen J Gange
Oct 24, 2008·PLoS Medicine·Lewis H KullerUNKNOWN INSIGHT SMART Study Group
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
May 16, 2009·AIDS·Adeel A ButtUNKNOWN Veterans Aging Cohort Study
Jun 10, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Roger J BedimoPablo Tebas
Aug 31, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Xiao DingKendall A Marcus
Sep 11, 2012·Journal of the American College of Cardiology·Kristian ThygesenDaniel R Wagner
Nov 29, 2012·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Amy C JusticeUNKNOWN NA-ACCORD and VACS Project Teams
Mar 6, 2013·JAMA Internal Medicine·Matthew S FreibergAmy C Justice
Oct 22, 2013·Immunity·Steven G DeeksDaniel C Douek
Mar 13, 2014·American Journal of Epidemiology·H M CraneUNKNOWN Centers for AIDS Research Network of Integrated Clinical Systems Cohort Investigators
Apr 25, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Manisha DesaiDouglas K Owens
May 2, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jim YoungUNKNOWN Swiss HIV Cohort Study
Nov 5, 2015·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Julia L MarcusMichael J Silverberg
May 19, 2017·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Daniel R DrozdHeidi M Crane

❮ Previous
Next ❯

Citations

Nov 22, 2018·Current Opinion in Infectious Diseases·Lisa HamzahFrank A Post
Apr 9, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Helen KovariUNKNOWN Swiss Human Immunodeficiency Virus Cohort Study
Nov 28, 2019·Expert Review of Clinical Pharmacology·Mary Clare MastersSusan E Cohn
Dec 7, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sahera Dirajlal-FargoGrace A McComsey
Jan 29, 2020·Current Opinion in HIV and AIDS·Aaron Richterman, Paul E Sax
Jul 16, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul E SaxUNKNOWN GS-US-380–4030 Investigators
Jun 12, 2019·Nature Reviews. Cardiology·Priscilla Y Hsue, David D Waters
Sep 11, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David B HannaSarah L Braunstein
Dec 10, 2019·AIDS Care·Julia FlemingUNKNOWN HIV Research Network
Apr 20, 2020·Tropical Medicine & International Health : TM & IH·David C BoettigerAlexandre Grangeiro
Jul 26, 2018·JAMA : the Journal of the American Medical Association·Michael S SaagPaul A Volberding
Dec 18, 2020·Arteriosclerosis, Thrombosis, and Vascular Biology·James H SteinJoseph C Delaney
Jun 27, 2019·Infectious Disease Clinics of North America·Sean G KellyBabafemi O Taiwo
Aug 10, 2019·Infectious Disease Clinics of North America·Brandon Dionne
Mar 30, 2021·Frontiers in Immunology·Morris MadzimeHelen C Steel
Jan 26, 2021·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Wouter A van der HeijdenQuirijn de Mast
Jun 15, 2021·Frontiers in Molecular Biosciences·Jieqing YuJing Ye
Sep 22, 2021·Current Opinion in HIV and AIDS·Alinda G Vos, W D F Venter
Jun 17, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pamela S DouglasUNKNOWN REPRIEVE Investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.